Literature DB >> 10968797

Chemotherapy for advanced colorectal cancer.

M Michael, J R Zalcberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968797      PMCID: PMC1118426          DOI: 10.1136/bmj.321.7260.521

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

1.  Global cancer statistics.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

2.  Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.

Authors: 
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

3.  Vinorelbine in advanced non-small cell lung cancer. A pharmacoeconomic review.

Authors:  A J Coukell; S Noble; D Faulds
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

4.  Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer.

Authors:  M Buyse; P Thirion; R W Carlson; T Burzykowski; G Molenberghs; P Piedbois
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

5.  Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

Authors:  P Piedbois; P Rougier; M Buyse; J Pignon; L Ryan; R Hansen; B Zee; B Weinerman; J Pater; C Leichman; J Macdonald; J Benedetti; J Lokich; J Fryer; G Brufman; R Isacson; A Laplanche; E Levy
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group.

Authors:  P C Simmonds
Journal:  BMJ       Date:  2000-09-02

7.  Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

Authors:  D J Bloomfield; M D Krahn; T Neogi; T Panzarella; T J Smith; P Warde; A R Willan; S Ernst; M J Moore; A Neville; I F Tannock
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

8.  General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy. A longitudinal study.

Authors:  B Glimelius; W Graf; K Hoffman; L Påhlman; P O Sjödén; A Wennberg
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

9.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 10.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

View more
  1 in total

1.  Chemotherapy for advanced color. Please aim for accuracy rather than hard hitting headlines.

Authors:  M M Kirollos
Journal:  BMJ       Date:  2001-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.